BACKGROUND: Cohort and case-crossover studies were conducted to evaluate whether new Helicobacter pylori infections are followed by increased diarrhea. METHODS: Participants were 6-month-old to 12-year-old shantytown residents living near Lima, Peru. Baseline data were collected from community households. Health interviews were completed daily, and sera, drawn every 4 months, were tested for H pylori immunoglobulin G. Diarrhea rates among newly H pylori-infected (seroconverting) children were compared with rates among persistently uninfected and infected children using cohort and case-crossover analyses. RESULTS: Sera were obtained from 345 children from January 1, 1995, through September 1, 1997. H pylori incidence was 12% per year (36 H pylori infections in 109 866 seronegative days). In adjusted cohort analyses, seroconverters had more diarrhea days (rate ratio: 2.0; 95% confidence interval: 1.6-2.4), episodes, and sick days in the year after infection than did uninfected children; and more diarrhea days and sick days than did persistently infected children. This effect was strongest in the first 2 months. Case-crossover analyses supported these findings. CONCLUSION: Preventing H pylori infection may help reduce pediatric diarrheal disease.
BACKGROUND: Cohort and case-crossover studies were conducted to evaluate whether new Helicobacter pylori infections are followed by increased diarrhea. METHODS:Participants were 6-month-old to 12-year-old shantytown residents living near Lima, Peru. Baseline data were collected from community households. Health interviews were completed daily, and sera, drawn every 4 months, were tested for H pylori immunoglobulin G. Diarrhea rates among newly H pylori-infected (seroconverting) children were compared with rates among persistently uninfected and infected children using cohort and case-crossover analyses. RESULTS: Sera were obtained from 345 children from January 1, 1995, through September 1, 1997. H pylori incidence was 12% per year (36 H pylori infections in 109 866 seronegative days). In adjusted cohort analyses, seroconverters had more diarrhea days (rate ratio: 2.0; 95% confidence interval: 1.6-2.4), episodes, and sick days in the year after infection than did uninfected children; and more diarrhea days and sick days than did persistently infected children. This effect was strongest in the first 2 months. Case-crossover analyses supported these findings. CONCLUSION: Preventing H pylori infection may help reduce pediatric diarrheal disease.
Authors: Richard L Guerrant; Mark D DeBoer; Sean R Moore; Rebecca J Scharf; Aldo A M Lima Journal: Nat Rev Gastroenterol Hepatol Date: 2012-12-11 Impact factor: 46.802
Authors: S Alison Finger; Billie Velapatiño; Margaret Kosek; Livia Santivañez; Daiva Dailidiene; Willi Quino; Jacqueline Balqui; Phabiola Herrera; Douglas E Berg; Robert H Gilman Journal: Appl Environ Microbiol Date: 2006-07 Impact factor: 4.792
Authors: Lucia Pacifico; John F Osborn; Valeria Tromba; Sara Romaggioli; Stefano Bascetta; Claudio Chiesa Journal: World J Gastroenterol Date: 2014-02-14 Impact factor: 5.742
Authors: Abd Al Nasser Al-Hawajri; Dan Keret; Albert Simhon; Amir Zlotkin; Yolanta Fishman; Herve Bercovier; Galia Rahav Journal: Dig Dis Sci Date: 2004-08 Impact factor: 3.199
Authors: Kate L Mandeville; Justus Krabshuis; Nimzing Gwamzhi Ladep; Chris J J Mulder; Eamonn M M Quigley; Shahid A Khan Journal: World J Gastroenterol Date: 2009-06-21 Impact factor: 5.742
Authors: Phabiola M Herrera; Melissa Mendez; Billie Velapatiño; Billie Velapatiõ; Livia Santivañez; Livia Santivaez; Jacqueline Balqui; S Alison Finger; Jonathan Sherman; Mirko Zimic; Lilia Cabrera; Jose Watanabe; Carlos Rodríguez; Robert H Gilman; Douglas E Berg Journal: J Clin Microbiol Date: 2008-10-08 Impact factor: 5.948
Authors: Ousman Secka; Douglas E Berg; Martin Antonio; Tumani Corrah; Mary Tapgun; Robert Walton; Vivat Thomas; Juan J Galano; Javier Sancho; Richard A Adegbola; Julian E Thomas Journal: Antimicrob Agents Chemother Date: 2012-12-21 Impact factor: 5.191